One of the most central genetic characteristics is the isocitrate dehydrogenase mutation (IDH1) status that is commonly expressed in low-grade gliomas and reflects a favorable prognosis relative to IDH1 wild-type gliomas that are high-grade glioblastomas [3,4]. The gene discussed is IDH1; the disease is glioma.